期刊
CELL DEATH & DISEASE
卷 4, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/cddis.2013.156
关键词
calreticulin; ATP; HMGB1; immunogenic cell death; TLRs
类别
资金
- Fund for Scientific Research Flanders (FWO-Vlaanderen) [G. 0728.10, 3G060713, 3G0A5413, 3G067512, G. 0642.10N]
- FWO-Vlaanderen [31507110, G.0875.11, G.0973.11, G.0A45.12N]
- Federal Research Programme [IAP 7/30]
- VIB, Ghent University (GROUP-ID Consortium of the UGent MRP initiative)
- European Research Programme FP6 ApopTrain [MRTN-CT-035624]
- Euregional PACTII
- Flemish Government [BOF09/01M00709]
- [200767]
A new concept of immunogenic cell death (ICD) has recently been proposed. The immunogenic characteristics of this cell death mode are mediated mainly by molecules called 'damage-associated molecular patterns' (DAMPs), most of which are recognized by pattern recognition receptors. Some DAMPs are actively emitted by cells undergoing ICD (e.g. calreticulin (CRT) and adenosine triphosphate (ATP)), whereas others are emitted passively (e.g. high-mobility group box 1 protein (HMGB1)). Recent studies have demonstrated that these DAMPs play a beneficial role in anti-cancer therapy by interacting with the immune system. The molecular pathways involved in translocation of CRT to the cell surface and secretion of ATP from tumor cells undergoing ICD are being elucidated. However, it has also been shown that the same DAMPs could contribute to progression of cancer and promote resistance to anticancer treatments. In this review, we will critically evaluate the beneficial and detrimental roles of DAMPs in cancer therapy, focusing mainly on CRT, ATP and HMGB1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据